267 related articles for article (PubMed ID: 26515660)
1. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.
Howard R; McShane R; Lindesay J; Ritchie C; Baldwin A; Barber R; Burns A; Dening T; Findlay D; Holmes C; Jones R; Jones R; McKeith I; Macharouthu A; O'Brien J; Sheehan B; Juszczak E; Katona C; Hills R; Knapp M; Ballard C; Brown RG; Banerjee S; Adams J; Johnson T; Bentham P; Phillips PP
Lancet Neurol; 2015 Dec; 14(12):1171-81. PubMed ID: 26515660
[TBL] [Abstract][Full Text] [Related]
2. Donepezil and memantine for moderate-to-severe Alzheimer's disease.
Howard R; McShane R; Lindesay J; Ritchie C; Baldwin A; Barber R; Burns A; Dening T; Findlay D; Holmes C; Hughes A; Jacoby R; Jones R; Jones R; McKeith I; Macharouthu A; O'Brien J; Passmore P; Sheehan B; Juszczak E; Katona C; Hills R; Knapp M; Ballard C; Brown R; Banerjee S; Onions C; Griffin M; Adams J; Gray R; Johnson T; Bentham P; Phillips P
N Engl J Med; 2012 Mar; 366(10):893-903. PubMed ID: 22397651
[TBL] [Abstract][Full Text] [Related]
3. The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis.
Killin LO; Russ TC; Starr JM; Abrahams S; Della Sala S
BMJ Open; 2014 Apr; 4(4):e004083. PubMed ID: 24710130
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation.
Hartz S; Getsios D; Tao S; Blume S; Maclaine G
BMC Neurol; 2012 Feb; 12():2. PubMed ID: 22316501
[TBL] [Abstract][Full Text] [Related]
5. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.
Reynolds CF; Butters MA; Lopez O; Pollock BG; Dew MA; Mulsant BH; Lenze EJ; Holm M; Rogers JC; Mazumdar S; Houck PR; Begley A; Anderson S; Karp JF; Miller MD; Whyte EM; Stack J; Gildengers A; Szanto K; Bensasi S; Kaufer DI; Kamboh MI; DeKosky ST
Arch Gen Psychiatry; 2011 Jan; 68(1):51-60. PubMed ID: 21199965
[TBL] [Abstract][Full Text] [Related]
6. Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
Chen R; Chan PT; Chu H; Lin YC; Chang PC; Chen CY; Chou KR
PLoS One; 2017; 12(8):e0183586. PubMed ID: 28827830
[TBL] [Abstract][Full Text] [Related]
7. Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities.
Meguro K; Ouchi Y; Akanuma K; Meguro M; Kasai M
BMC Neurol; 2014 Dec; 14():243. PubMed ID: 25516360
[TBL] [Abstract][Full Text] [Related]
8. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease.
Kim SH; Kandiah N; Hsu JL; Suthisisang C; Udommongkol C; Dash A
Br J Pharmacol; 2017 Dec; 174(23):4224-4232. PubMed ID: 28901528
[TBL] [Abstract][Full Text] [Related]
9. Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer's disease and chronic obstructive pulmonary disease: a retrospective observational study.
Cao Y; Qian L; Yu W; Li T; Mao S; Han G
J Int Med Res; 2020 Feb; 48(2):300060520902895. PubMed ID: 32046559
[TBL] [Abstract][Full Text] [Related]
10. Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology.
Sabbagh M; Cummings J
BMC Neurol; 2011 Feb; 11():21. PubMed ID: 21299848
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.
Dysken MW; Guarino PD; Vertrees JE; Asthana S; Sano M; Llorente M; Pallaki M; Love S; Schellenberg GD; McCarten JR; Malphurs J; Prieto S; Chen P; Loreck DJ; Carney S; Trapp G; Bakshi RS; Mintzer JE; Heidebrink JL; Vidal-Cardona A; Arroyo LM; Cruz AR; Kowall NW; Chopra MP; Craft S; Thielke S; Turvey CL; Woodman C; Monnell KA; Gordon K; Tomaska J; Vatassery G
Alzheimers Dement; 2014 Jan; 10(1):36-44. PubMed ID: 23583234
[TBL] [Abstract][Full Text] [Related]
12. A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa
Kim HJ; Shim Y; Han HJ; Kim BC; Park KH; Moon SY; Choi SH; Yang DW; Yoon B; Kim EJ; Jeong JH; Han SH
Neurol Ther; 2023 Aug; 12(4):1221-1233. PubMed ID: 37245175
[TBL] [Abstract][Full Text] [Related]
13. Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil.
Pietrzak RH; Maruff P; Snyder PJ
J Nutr Health Aging; 2009 Mar; 13(3):268-73. PubMed ID: 19262966
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.
Lopez OL; Becker JT; Wahed AS; Saxton J; Sweet RA; Wolk DA; Klunk W; Dekosky ST
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):600-7. PubMed ID: 19204022
[TBL] [Abstract][Full Text] [Related]
15. [Russian experience in using a combination of fixed doses of donepezil and memantine in the treatment of Alzheimer's disease as an observational non-interventional multicenter program].
Kolykhalov IV; Mkhitaryan EA; Fedorova YB; Ponomareva EV; Selezneva ND; Cherdak MA; Dudchenko NG; Seyfedinova AB; Isaev RI; Gavrilova SI; Tkacheva ON
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):69-75. PubMed ID: 38147385
[TBL] [Abstract][Full Text] [Related]
16. A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers.
Boinpally R; Chen L; Zukin SR; McClure N; Hofbauer RK; Periclou A
Clin Drug Investig; 2015 Jul; 35(7):427-35. PubMed ID: 26016820
[TBL] [Abstract][Full Text] [Related]
17. Memantine benefits functional abilities in moderate to severe Alzheimer's disease.
Winblad B; Gauthier S; Aström D; Stender K
J Nutr Health Aging; 2010 Nov; 14(9):770-4. PubMed ID: 21085908
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
Lee W; Kim M
Medicine (Baltimore); 2024 Jun; 103(24):e38067. PubMed ID: 38875437
[TBL] [Abstract][Full Text] [Related]
19. The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France.
Touchon J; Lachaine J; Beauchemin C; Granghaud A; Rive B; Bineau S
Eur J Health Econ; 2014 Nov; 15(8):791-800. PubMed ID: 23928827
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
Zhang Y; Lin C; Zhang L; Cui Y; Gu Y; Guo J; Wu D; Li Q; Song W
PLoS One; 2015; 10(6):e0130353. PubMed ID: 26076022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
